Wed, Apr 23, 2014, 9:33 AM EDT - U.S. Markets close in 6 hrs 27 mins

Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • enabeler enabeler Apr 4, 2013 11:35 AM Flag

    Better and more news leads to shorts pressing the issue even harder.

    It's so orchestrated and manipulated that it defies credulity. Is there no one or any institutional holder that can force the issue? Does Nasdaq and/or the SEC even give a damn?

    "Free" markets are non-existent when it comes to small cap Nasdaq stocks. I know I'm "free" to sell, but the idea is that if you build a better mousetrap they'll beat a path to your door.

    In the same vein, why has the FDA delayed bestowing cabozantinib with a "breakthrough" status? Only 3 drugs have been so designated. Cabo is already approved for MTC, it has remarkable and almost miraculous effects on bone metastasis in prostate cancer and has proven and repeatable progression free survival in a dozen cancer indications. I know it's not overall survival stats, but that takes time, which is why "breakthrough" designation is so appropriate in this case.

    Considering all these "facts" and the GDC0973 connection with Roche/Genentech, it seems incomprehensible for the stock and the overall market value to be so low.

    Frustrating doesn't quite cover the feeling. It is a deep and tragic disappointment in the "free market" system that hurts much more than just the lost of money or opportunity.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
EXEL
3.56-0.02(-0.56%)9:32 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.